Author

Merle Riedemann

Institutions: Brigham and Women's Hospital, Harvard University

Observed institutions: Brigham and Women's Hospital, Harvard University

ORCID: 0009-0004-5457-7451

Observed ORCID: 0009-0004-5457-7451

OpenAlex ID: A5115797279

Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications

2025 · Mifra Faiz, Merle Riedemann, et al. · Current Hematologic Malignancy Reports · 8

Mutant ASXL1 exacerbates CALR-mutant myeloproliferative neoplasms by enhancing a distinct megakaryocyte differentiation program

2026 · Frederike Kramer, Merle Riedemann, et al. · Journal of Clinical Investigation

Works count: 2

Citation count: 8

H-index: 1

I10-index: